Johannes Sam

Person

Schlieren, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies binding to HLA-A2/WT1
- Patent number 12,098,213
- Issue date Sep 24, 2024
- HOFFMANN-LA ROCHE INC.
- Joerg Benz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antigen binding molecules targeting OX40 and FAP
- Patent number 11,780,919
- Issue date Oct 10, 2023
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and...
- Patent number 11,718,680
- Issue date Aug 8, 2023
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tumor-targeted agonistic CD28 antigen binding molecules
- Patent number 11,608,376
- Issue date Mar 21, 2023
- HOFFMANN-LA ROCHE INC.
- Guy Georges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies binding to HLA-A2/WT1
- Patent number 11,192,957
- Issue date Dec 7, 2021
- HOFFMANN-LA ROCHE INC.
- Joerg Benz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating CEA-positive cancers using PD-1 axis binding an...
- Patent number 10,596,257
- Issue date Mar 24, 2020
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM
- Publication number 20240368309
- Publication date Nov 7, 2024
- HOFFMANN-LA ROCHE INC.
- Stephan GASSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP
- Publication number 20240117049
- Publication date Apr 11, 2024
- HOFFMANN-LA ROCHE INC.
- Maria AMANN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND...
- Publication number 20240109976
- Publication date Apr 4, 2024
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATES...
- Publication number 20240092856
- Publication date Mar 21, 2024
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTION OR MITIGATION OF T-CELL ENGAGING AGENT-RELATED ADVERSE E...
- Publication number 20230416412
- Publication date Dec 28, 2023
- HOFFMANN-LA ROCHE INC.
- Gabrielle LECLERCQ-COHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES
- Publication number 20230416365
- Publication date Dec 28, 2023
- HOFFMANN-LA ROCHE INC.
- Guy GEORGES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BIS...
- Publication number 20230355754
- Publication date Nov 9, 2023
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies binding To HLA-A2/WT1
- Publication number 20220411534
- Publication date Dec 29, 2022
- HOFFMANN-LA ROCHE INC.
- Joerg Benz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP
- Publication number 20220025046
- Publication date Jan 27, 2022
- HOFFMANN-LA ROCHE INC.
- Maria AMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMBINATION OF 4-1 BB AGONISTS WITH ANTI-CD20 ANTIBODIES
- Publication number 20210163617
- Publication date Jun 3, 2021
- HOFFMANN-LA ROCHE INC.
- Claudia FERRARA KOLLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH TARGETED 4-1BB (CD137) AGONISTS
- Publication number 20210095002
- Publication date Apr 1, 2021
- HOFFMANN-LA ROCHE INC.
- Christina CLAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy with targeted OX40 agonists
- Publication number 20200392237
- Publication date Dec 17, 2020
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING CEA-POSITIVE CANCERS USING PD-1 AXIS BINDING AN...
- Publication number 20200376119
- Publication date Dec 3, 2020
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND...
- Publication number 20200325238
- Publication date Oct 15, 2020
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BIS...
- Publication number 20200306373
- Publication date Oct 1, 2020
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES
- Publication number 20200199234
- Publication date Jun 25, 2020
- HOFFMANN-LA ROCHE INC.
- Guy GEORGES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TYPE II ANTI-CD20 ANTIBODY AND ANTI-CD20/CD3 BISPECIFIC ANTIBODY FO...
- Publication number 20200172627
- Publication date Jun 4, 2020
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies binding To HLA-A2/WT1
- Publication number 20190248916
- Publication date Aug 15, 2019
- HOFFMANN-LA ROCHE INC.
- Joerg Benz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CEA-POSITIVE CANCERS USING PD-1 AXIS BINDING AN...
- Publication number 20180000931
- Publication date Jan 4, 2018
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Johannes Sam

Person

Patents Grantslast 30 patents

Antibodies binding to HLA-A2/WT1

Bispecific antigen binding molecules targeting OX40 and FAP

Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and...

Tumor-targeted agonistic CD28 antigen binding molecules

Antibodies binding to HLA-A2/WT1

Methods of treating CEA-positive cancers using PD-1 axis binding an...

Patents Applicationslast 30 patents

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM

BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP

COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND...

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATES...

PREVENTION OR MITIGATION OF T-CELL ENGAGING AGENT-RELATED ADVERSE E...

TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES

COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BIS...

Antibodies binding To HLA-A2/WT1

BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP

THERAPEUTIC COMBINATION OF 4-1 BB AGONISTS WITH ANTI-CD20 ANTIBODIES

COMBINATION THERAPY WITH TARGETED 4-1BB (CD137) AGONISTS

Combination therapy with targeted OX40 agonists

METHODS OF TREATING CEA-POSITIVE CANCERS USING PD-1 AXIS BINDING AN...

COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND...

COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BIS...

TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES

TYPE II ANTI-CD20 ANTIBODY AND ANTI-CD20/CD3 BISPECIFIC ANTIBODY FO...

Antibodies binding To HLA-A2/WT1

METHODS OF TREATING CEA-POSITIVE CANCERS USING PD-1 AXIS BINDING AN...